TNF, IL6, and IL1B polymorphisms are associated with severe influenza a (H1N1) virus infection in the Mexican Population

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  García Ramírez, Román Alejandro ^a,b,c   Ramírez Venegas, Alejandra ^c   Quintana Carrillo, Roger ^c   Camarena, Angel Eduardo ^c   Falfán Valencia, Ramcés ^c   Mejía Aranguré, Juan Manuel ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CASE CONTROL STUDY; CCL1 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IL1B GENE; IL6 GENE; IL8 GENE; INFLUENZA A (H1N1); LT GENE; MAJOR CLINICAL STUDY; MALE; MEXICAN; MORTALITY; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TNF GENE; EPIDEMIOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; INFLUENZA; INFLUENZA A VIRUS (H1N1); ISOLATION AND PURIFICATION; MEXICO; MIDDLE AGED; RISK FACTOR; VIROLOGY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957110780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144832     Document Type: Article

References (43)

1. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González León M. et al. Infection and death from influenza A H1N1 virus in Mexico: A retrospective analysis. Lancet. 2009; 374(9707): 2072-2079. doi: 10.1016/S0140-6736(09)61638-X
2. Morales-García G, Falfán-Valencia R, García-Ramírez RA, Camarena A, Ramirez-Venegas A, Castillejos López M. et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: A case-control study. BMC Infect Dis. 2012; 12: 299. doi: 10. 1186/1471-2334-12-299
3. Yu X, Zhang X, Zhao B, Wang J, Zhu Z. Teng Z et al. Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS ONE. 2011 6(12): e28680. doi: 10.1371/journal.pone.0028680
4. Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L. et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010; 14(5): R167. doi: 10.1186/cc9259
5. Zúñiga J, Torres M, Romo J, Torres D, Jiménez L, Ramírez G. et al. Inflammatory profiles in severe pneumonia associated with the pandemic influenza A/H1N1 virus isolated in Mexico City. Autoimmunity. 2011; 44(7): 562-570. doi: 10.3109/08916934.2011.592885
6. Hagau A., Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care. 2010; 14(6): R203. doi: 10. 1186/cc9324
7. Chiaretti A, Pulitano S, Conti G, Barone G, Buonsenso D, et al. Interleukin and neurotrophin up-regulation correlates with severity of H1N1 infection in children: A case-control study. Int J Infect Dis. 2013; 17(12): e1186-1193. doi: 10.1016/j.ijid.2013.07.006
8. Estella A. Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A (H1N1)v severe pneumonia. J Infect Dev Ctries. 2011; 5(7): 540-543. .
9. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995; 108(5): 1303-1314.
10. Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, et al. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther. 2011; 16:237-247. doi: 10.3851/IMP1722
11. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010; 50:850-859. doi: 10.1086/650581
12. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995; 99(2): 303-310.
13. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians. 1999; 111(4): 290-298.
14. Romanova E. N. and Govorin A. V. TNF-Alpha, IL-10, and eNOS gene polymorphisms in patients with influenza A/H1N1 complicated by pneumonia. Ter Arkh. 2013; 85(3): 58-62.
15. Antonopoulou A, Baziaka F, Tsaganos T, Raftogiannis M, Koutoukas P, Spyridaki A. et al. Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection. Int J Infect Dis. 2012. 16(3): e204-208. doi: 10.1016/j.ijid.2011.11.012
16. Martinez-Ocaña J, Olivo-Diaz A, Salazar-Dominguez T, Reyes-Gordillo J, Tapia-Aquino C, Martínez Hernández F. et al. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09. J Clin Virol. 2013; 58(1): 108-113. doi: 10.1016/j.jcv. 2013.05.013
17. Borja-Aburto VH, Chowell G, Viboud C, Simonsen L, Miller MA, Grajales Muñíz C. et al. Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity. Arch Med Res. 2012; 43(7): 563-570. doi: 10.1016/j.arcmed.2012.09.005
18. Julkunen I, Pyhälä R, Hovi T. Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis. J Virol Methods; 1985. 10:75-84.
19. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M. et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009; 460:1021-5. doi: 10.1038/nature08260
20. Sinha S, Mishara SK, Sharma S, Patibandla PK, Mallick PK, Sharma SK et al. Indian Genome Variation Consortium, Venkatesh V, Habib S. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J. 20 7: 13.
21. Liu Y, Li S, Zhang G, Nie G, Meng Z, Mao D et al. Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus. BMC Immunol. 2013. 14: 37. doi: 10.1186/1471-2172-14-37
22. Lanas A, García-González MA, Santolaria S, Crusius JB, Serrano MT, Benito R et al. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun. 2001; 2(8): 415-421.
23. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America. 1997; 94(7): 3195-3199.
24. Kerr JR, McCoy M, Burke B, Mattey DL, Pravica V, Hutchinson IV. Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J Clin Pathol. 2003; 56(10): 725-727.
25. Atan D, Heissigerova J, Kuffová L Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. Mol Vis. 2013; 19: 184-195.
26. Broekhuizen R, Grimble RF, Howell WM, Shale DJ, Creutzberg EC, Wouters EF et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta-511 single nucleotide polymorphism. Am J Clin Nutr. 2005; 82(5): 1059-1064.
27. Chiaretti A, Genovese O, Aloe L, Antonelli A, Piastra M, Polidori G et al. Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst. 2005; 21(3): 185-193; discussion 194.
28. Wu CL, Lee YL, Chang KM, Chang GC, King SL, Chiang CD et al. Bronchoalveolar interleukin-1 beta: A marker of bacterial burden in mechanically ventilated patients with community-Acquired pneumonia. Crit Care Med. 2003; 31(3): 812-817.
29. Paich HA, Sheridan PA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens MG, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring). 2013; 21(11):2377-86.
30. Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I. et al. Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun. 2004; 5(6): 505-512.
31. Sato M, Hosoya M., Wright PF Differences in serum cytokine levels between influenza virus A and B infections in children. Cytokine. 2009; 47(1): 65-68.
32. Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, León AJ et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS ONE. 2012; 7(6): e38214.
33. Seki M, Yanagihara K., Higashiyama Y, Fukuda Y, Kaneko Y, Ohno H. et al. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J. 2004; 24(1): 143-149. doi: 10. 1371/journal.pone.0038214
34. Chiaretti A, Pulitanó S, Barone G, Ferrara P, Romano V, Capozzi D et al. IL-1 beta and IL-6 upregulation in children with H1N1 influenza virus infection. Mediators Inflamm. 2013; 495848. doi: 10.1155/2013/495848
35. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998; 101(2): 311-320.
36. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, et al.Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men. Arterioscler Thromb Vasc Biol. 2006; 26(4):871-6.
37. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol. 2007; 6: 27.
38. Yu X., Zhang X., Zhao B., Wang J., Zhu Z, Teng Z et al.Intensive Cytokine induction in Pandemic H1N1 Influenza Virus Infection Accompanied by Robust Production of IL-10 and IL-6.PLoS One. 2011; 6(12): e28680. doi: 10.1371/journal.pone.0028680
39. Higuera Iglesias, Kudo K., Manabe T., Corcho BA, Corrales A, Alfaro Ramos L et al. Reducing Occurrence and Severity of Pneumonia Due to Pandemic H1N1 2009 by Early Oseltamivir Administration: A Retrospective Study in Mexico. PLoS One. 2011; 6(7):e21838. doi: 10.1371/journal.pone.0021838
40. Gómez-Gómez A, Magaña-Aquino M, Garcia-Sepúlveda C, Ochoa-Pérez UR, Falcón-Escobedo R, Comas Garcia A et al. Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico. Emerg Infect Dis. 2010; 16(1):27-34. doi: 10.3201/eid1601.090941
41. Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Grajales Muñiz C, Rascón Pacheco et al. Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity. Version 2. PLoS Curr. 2012; 4:RRN1306.
42. Dávila J, Chowell G, Borja-Aburto VH, Viboud C, Grajales Muñiz C, Miller M. Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity. PLoS Curr. 2014; 6.
43. Jiménez-Corona ME, Aguilar-Díaz F del C, León-Solís LE, Morales-Virgen JJ, de León-Rosales SP Knowledge, attitudes and practices about influenza A(H1N1) 2009, and influenza vaccine in Mexico: results of a population survey. Salud Publica Mex. 2012; 54(6):607-15.